EDGAR Filing Documents for 0001564590-15-002066

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:

SEC Accession No. 0001564590-15-002066

Filing Date

2015-03-27

Accepted

2015-03-27 17:17:25

Documents

Period of Report

2014-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	10-K	rare-10k_20141231.htm	10-K	3370521
2	EX-10.34	rare-ex1034_201412311155.htm	EX-10.34	30449
3	EX-23.1	rare-ex231_20141231824.htm	EX-23.1	2801
4	EX-31.1	rare-ex311_2014123123.htm	EX-31.1	14623
5	EX-31.2	rare-ex312_2014123124.htm	EX-31.2	14620
6	EX-32.1	rare-ex321_2014123125.htm	EX-32.1	9937
7	GRAPHIC	g201503272100201011208.jpg	GRAPHIC	50407
8	GRAPHIC	g201503272100063041207.jpg	GRAPHIC	79868
	Complete submission text file	0001564590-15-002066.txt		15661726

Data Files

Seq	Description	Document	Type	Size
9	XBRL INSTANCE DOCUMENT	rare-20141231.xml	EX-101.INS	2595890
10	XBRL TAXONOMY EXTENSION SCHEMA	rare-20141231.xsd	EX-101.SCH	66819
11	XBRL TAXONOMY EXTENSION CALCULATION LINKBASE	rare-20141231_cal.xml	EX-101.CAL	50368
12	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE	rare-20141231_def.xml	EX-101.DEF	285135
13	XBRL TAXONOMY EXTENSION LABEL LINKBASE	rare-20141231_lab.xml	EX-101.LAB	533647
14	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	rare-20141231_pre.xml	EX-101.PRE	431859

Mailing Address 60 LEVERONI COURT NOVATO CA 94949

Business Address 60 LEVERONI COURT NOVATO CA 94949 415-483-8800

Ultragenyx Pharmaceutical Inc. (Filer) CIK: 0001515673 (see all company filings)